Cited by 47Hepatocellular Carcinoma Treatment and PrognosisAlcohol Consumption and Health EffectsHead and Neck Cancer Studies

Global Prevalence, Clinical Characteristics, Surveillance, Treatment Allocation, and Outcomes of Alcohol-Associated Hepatocellular Carcinoma

Zeng, Rebecca Wenling, Ong, Christen En Ya, Ong, Elden Yen Hng, Chung, Charlotte Hui, Lim, Wen Hui, Xiao, Jieling, Danpanichkul, Pojsakorn, Law, Jia Hao +17 more·2024·Clinical Gastroenterology and Hepatology

Abstract

Background Although the burden of alcohol-associated hepatocellular carcinoma (HCC) is increasing with rising alcohol consumption, clinical presentation and outcomes of alcohol-associated HCC have not been systematically assessed. We aimed to determine the prevalence, clinical characteristics, surveillance rates, treatment allocation, and outcomes of alcohol-associated HCC.Methods Medline and Embase were searched from inception to January 2023. Proportional data were analyzed using a generalized linear mixed model. The odds ratio (OR) or mean difference comparing alcohol-associated HCC and other causes was obtained with pairwise meta-analysis. Survival outcomes were evaluated using a pooled analysis of hazard ratios.Results Of 4824 records identified, 55 articles (86,345 patients) were included. Overall, 30.4% (95% confidence interval [CI], 24.0%-37.7%) of HCC was alcohol associated, with the highest proportion in Europe and the lowest in the Americas. People with alcohol-associated HCC were more likely male but were similar in age and comorbidities compared with other causes. A total of 20.8% (95% CI, 11.4%-34.9%) of people with alcohol-associated HCC underwent surveillance compared with 35.0%, 31.6%, and 21.4% in hepatitis B virus, hepatitis C virus, and metabolic dysfunction-associated HCC, respectively (all P < .05). Alcohol-associated HCC had a lower likelihood of Barcelona Clínic Liver Cancer C stage (0/A) (OR, 0.7; 95% CI, 0.6-0.9; P = .018) and curative therapy (24.5% vs 33.9%; OR, 0.7; 95% CI, 0.5-0.9; P = .003), and higher mortality (HR, 1.3; 95% CI, 1.1-1.5; P = .012) when compared with other causes.Conclusions Alcohol-associated HCC is associated with lower surveillance rates, more advanced BCLC stage, lower likelihood of receiving curative therapy, and poorer survival. These data call for measures to reduce heavy alcohol consumption and improve strategies for effective HCC surveillance in high-risk individuals.

Integrity signals

Registry

Crossref · 10.1016/j.cgh.2024.06.026

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Improved screening and diagnostic techniques allow for earlier and more accurate detection, while changes in disease registry systems may enhance the ability to capture current epidemiological trends, potentially leading to higher reported prevalence rates.

    “Improved screening and diagnostic techniques allow for earlier and more accurate detection, while changes in disease registry systems may enhance the ability to capture current epidemiological trends, potentially leading to higher reported prevalence rates [27,28].”

Cites

Flagged first, then by citations

2 of the 95 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Zeng, R. W., Ong, C. E. Y., Ong, E. Y. H., Chung, C. H., Lim, W. H., Xiao, J., Danpanichkul, P., Law, J. H., Syn, N., Chee, D., Kow, A. W. C., Lee, S. W., Takahashi, H., Kawaguchi, T., Tamaki, N., Dan, Y. Y., Nakajima, A., Wijarnpreecha, K., Muthiah, M. D., Noureddin, M., Loomba, R., Ioannou, G. N., Tan, D. J. H., Ng, C. H., & Huang, D. Q.
Affiliations
  • National University of Singapore (SG)
  • Chiang Mai University (TH)
  • National University Hospital (SG)
  • National University Cancer Institute, Singapore (SG)
  • Catholic University of Korea (KR)
  • Kurume University (JP)
  • Musashino Red Cross Hospital (JP)
  • Yokohama City University (JP)
  • Banner Health (US)
  • University of California San Diego (US)
  • University of Washington (US)
Corresponding author
Huang, Daniel Q.
Venue
Clinical Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2024-12
Volume
22
Issue
12
Pages
2394-2402.e15
ISSN
1542-3565 (ISSN-L)
OpenAlex
W4400429106
Cited by
47
References
95
Citations by year
2026: 13 · 2025: 27 · 2024: 7
FWCI
3.39
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Gastroenterology and Hepatology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (UL1TR001442)
  • National Institute on Alcohol Abuse and Alcoholism (U01AA029019)
  • National Heart, Lung, and Blood Institute (P01HL147835)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124318, R01DK121378, R01DK106419, P30DK120515, U01DK061734, U01DK130190)
Topics
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
  • Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
Keywords
alcohol consumption, cancer surveillance, treatment allocation, curative treatment, Barcelona Clinic Liver Cancer staging, survival outcomes, mortality, hepatitis B virus, hepatitis C virus, non-alcoholic fatty liver disease, global burden
MeSH terms
Female, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Global Health, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review